Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Enzymatic Synthesis of a Novel α-Linolenic Acid-Enriched Phytoceramide From Perilla Seed Oil and Its Multifunctional Bioactivity in Skin Barrier Repair and Anti-Aging.

Created on 12 Oct 2026

Authors

Jumao Yuan, Ning Hao, Borui Shi, Zhenzhen Wang, Jie Yu, Nuo Shi, Lin Lin

Published in

Chemistry & biodiversity. Volume 23. Issue 10. Pages e71808.

Abstract

Ceramides are essential lipid components of the skin barrier, accounting for approximately 50% of intercellular lipids in the stratum corneum. Their deficiency is associated with various skin disorders, including atopic dermatitis and xerosis. This study aimed to enzymatically synthesize a novel phytoceramide from perilla seed oil (PSO-Cer) and evaluate its multifaceted bioactivity, including skin barrier enhancement and anti-aging effects, in comparison with oleic acid-derived Ceramide IIIB. PSO-Cer was synthesized enzymatically and characterized by HPLC-CAD and LC-QTOF. Its biological effects were assessed in human keratinocytes (HaCaT) and dermal fibroblasts-adult (HDF-a) through cytotoxicity assays, qPCR of genes related to barrier function and extracellular matrix (ECM) synthesis, western blot, and transcriptome sequencing. HPLC-CAD confirmed PSO-Cer was rich in polyunsaturated fatty acid chains, notably α-linolenic acid (34.49%). Both PSO-Cer and Ceramide IIIB were non-cytotoxic up to 25 µg/mL and significantly upregulated genes critical for epidermal barrier function (FLG, IVL, TGM1, CERS3, and ELOVL4) and ECM components (COL1A1, COL3A1, and ELN) in UVB-irradiated fibroblasts. Transcriptome analysis revealed that while both ceramides shared common mechanisms, namely activation of mTOR signaling and sphingolipid metabolism, PSO-Cer exhibited distinct properties, positioning it as a promising multifunctional active for advanced skincare formulations aimed at comprehensive skin health.

PMID:
42860858
Bibliographic data and abstract were imported from PubMed on 12 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement